Rates and Predictors of Nonadherence to the Post Allogeneic Hematopoietic Cell Transplant Medical Regimen in Patients and Caregivers

Successful allogeneic hematopoietic cell transplant (HCT) treatment for hematological disease requires a complex, multicomponent medical regimen be followed by patients with the help of their caregivers after hospital discharge.1, 2 Patients are most immunocompromised during the first 100 days post-HCT3, thus the initial period at home after discharge is highly important. During this immunocompromised period, patients are at particular risk for graft rejection, opportunistic infections, graft-versus-host disease, and related complications.

Source: Biology of Blood and Marrow Transplantation - December 4, 2021 Category: Hematology Authors: Donna M. Posluszny, Dana H. Bovbjerg, Karen L. Syrjala, Mounzer Agha, Rafic Farah, Jing-Zou Hou, Anastasios Raptis, Annie P. Im, Kathleen A. Dorritie, Michael M. Boyiadzis, Mary Amanda Dew Source Type: research